FMP
NASDAQ
29.57 USD
1.07 (3.62%)
Mr. Timothy P. Noyes M.B.A.
Healthcare
Biotechnology
https://aerovatetx.com
NASDAQ
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
0001798749
US0080641071
008064107
930 Winter Street
617 443 2400
US
51
Jun 30, 2021
0001798749
NASDAQ
Biotechnology
Healthcare
008064107
US0080641071
US
29.57
1.17
117.78k
823.91M
-
9.41-29.99
0.87
-
-
-
-
-10.3
-
https://aerovatetx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.